Goserelin EP Impurity J is a minor related variant formed during goserelin production. Sequence or oxidation differences produce characteristic shifts in retention time and structural stability. Researchers use it to validate impurity profiling techniques. Applications include QC evaluation, degradation-pathway analysis, and synthetic-route optimization.
CAT No: Z10-101-237
Synonyms/Alias:(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[(2S)-2-[(carbamoylamino)carbamoyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide; endo-8a-L-proline-goserelin
Goserelin EP Impurity J is a chemically defined peptide impurity associated with the synthesis and quality assessment of goserelin, a synthetic decapeptide analog of luteinizing hormone-releasing hormone (LHRH). As a structurally related byproduct, this impurity arises during the complex peptide manufacturing process and is of significant interest in analytical, regulatory, and pharmaceutical research settings. Its precise identification and characterization are essential for ensuring the integrity, safety, and efficacy of goserelin formulations, making it a critical reference standard and research tool in the field of peptide chemistry and pharmaceutical development.
Analytical method development: Goserelin EP Impurity J serves as an indispensable reference compound in the development and validation of analytical methods for peptide drugs. Researchers employ it to establish the sensitivity, specificity, and robustness of chromatographic techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry. By incorporating this impurity into analytical workflows, laboratories can reliably detect and quantify trace levels of structurally similar byproducts within goserelin formulations, supporting comprehensive impurity profiling and facilitating regulatory compliance in quality control environments.
Impurity profiling and characterization: In the context of pharmaceutical research and manufacturing, accurate identification and quantification of peptide-related impurities are paramount. This impurity enables detailed studies into the formation pathways, chemical stability, and degradation mechanisms of goserelin and its analogs. Its use in forced degradation and stability-indicating studies enhances understanding of the impurity landscape, supporting efforts to optimize synthetic protocols and improve overall product quality.
Peptide synthesis optimization: The presence of Goserelin EP Impurity J in manufacturing streams provides valuable feedback for process chemists aiming to refine peptide synthesis strategies. By monitoring the occurrence and concentration of this impurity, scientists can identify problematic reaction steps, reagent incompatibilities, or purification inefficiencies. Such insights drive the development of more selective synthetic routes and purification methods, ultimately reducing impurity burdens and increasing yield and reproducibility in peptide production.
Reference standard for regulatory submissions: Regulatory agencies require comprehensive documentation of all known impurities present in pharmaceutical products. Goserelin EP Impurity J is frequently utilized as a reference standard in the preparation of regulatory dossiers, batch release testing, and pharmacopoeial compliance studies. Its availability supports accurate impurity quantification, ensuring that manufacturers can demonstrate adherence to stringent quality standards and provide transparent impurity profiles for global regulatory submissions.
Pharmaceutical research and development: Beyond its role in quality control, this impurity is valuable in broader research contexts, such as evaluating the pharmacological specificity of goserelin formulations. By isolating and studying the biological and physicochemical properties of Goserelin EP Impurity J, researchers can assess its potential impact on formulation stability, peptide activity, and downstream processing. These investigations contribute to a deeper understanding of peptide drug safety, stability, and performance, informing both current manufacturing practices and future product development.
3. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
5. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More